Roy H. Perlis

Artificial Intelligence · 2001–2021

A researcher in the Science corpus: 16 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Artificial Intelligence — 7 citations into it

Whom Roy H. Perlis trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. David M. Blei

Papers from Roy H. Perlis's perspective

Ordered by how strongly the researchers Roy H. Perlis trusts endorse each paper. Same corpus, a different order for every researcher.

1. Finding scientific topics
2. Supervised Topic Models
3. The long-term natural history of the weekly symptomatic status of bipolar I disorder. (Archives of General Psychiatry)
4. Exponentiated Gradient Versus Gradient Descent for Linear Predictors
5. Effectiveness of adjunctive antidepressant treatment for bipolar depression. (New England Journal of Medicine)
6. 10 Years of GWAS Discovery: Biology, Function, and Translation. (American Journal of Human Genetics)
7. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. (Archives of General Psychiatry)
8. Probabilistic topic models
9. Unfolding Physiological State: Mortality Modelling in Intensive Care Units
10. The support of human genetic evidence for approved drug indications (Nature Genetics)

Their papers

• A mega-analysis of genome-wide association studies for major depressive disorder (2012) — 1,096 citations
• Genome-wide association study of over 40,000 bipolar disorder cases provides new insights into the underlying biology (2021) — 994 citations
• Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning (2019) — 667 citations
• Identification of common genetic risk variants for autism spectrum disorder (2019) — 2,059 citations
• Genomic dissection of bipolar disorder and schizophrenia including 28 subphenotypes (2018) — 667 citations
• Supervised topic models for clinical interpretability (2016) — 9 citations
• Identification of 15 genetic loci associated with risk of major depression in individuals of European descent (2016) — 756 citations
• Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways (2015) — 750 citations
• The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders (2013) — 664 citations
• Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder (2008) — 1,273 citations
• Whole-genome association study of bipolar disorder (2008) — 739 citations
• Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). (2006) — 642 citations
• Molecular genetics of attention-deficit/hyperactivity disorder. (2005) — 1,307 citations
• Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). (2004) — 865 citations
• Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision) (2003) — 780 citations
• [Detection, evaluation, and treatment of high blood cholesterol in adults]. (2001) — 1,619 citations